A membrane-interactive surface on the factor VIII C1 domain cooperates with the C2 domain for cofactor function.

Factor VIII binds to phosphatidylserine (PS)-containing membranes through its tandem, lectin-homology, C1 and C2 domains. However, the details of C1 domain membrane binding have not been delineated. We prepared 4 factor VIII C1 mutations localized to a hypothesized membrane-interactive surface (Arg2090Ala/Gln2091Ala, Lys2092Ala/Phe2093Ala, Gln2042Ala/Tyr2043Ala, and Arg2159Ala). Membrane binding and cofactor activity were measured using membranes with 15% PS, mimicking platelets stimulated by thrombin plus collagen, and 4% PS, mimicking platelets stimulated by thrombin. All mutants had at least 10-fold reduced affinities for membranes of 4% PS, and 3 mutants also had decreased apparent affinity for factor X. Monoclonal antibodies against the C2 domain produced different relative impairment of mutants compared with wild-type factor VIII. Monoclonal antibody ESH4 decreased the V(max) for all mutants but only the apparent membrane affinity for wild-type factor VIII. Monoclonal antibody BO2C11 decreased the V(max) of wild-type factor VIII by 90% but decreased the activity of 3 mutants more than 98%. These results identify a membrane-binding face of the factor VIII C1 domain, indicate an influence of the C1 domain on factor VIII binding to factor X, and indicate that cooperation between the C1 and C2 domains is necessary for full activity of the factor Xase complex.

[1]  P. Fay,et al.  Factor VIII Lacking the C2 Domain Retains Cofactor Activity in Vitro* , 2010, The Journal of Biological Chemistry.

[2]  Gerry A. F. Nicolaes,et al.  Trp2313-His2315 of Factor VIII C2 Domain Is Involved in Membrane Binding , 2010, The Journal of Biological Chemistry.

[3]  Virgil L. Woods,et al.  Effect of Membrane Binding Upon Intramolecular Dynamics of the Factor VIII C2 Domain. , 2009 .

[4]  G. E. Gilbert,et al.  Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity. , 2009, Blood.

[5]  Y. Sakata,et al.  The Factor VIIIa C2 Domain (Residues 2228–2240) Interacts with the Factor IXa Gla Domain in the Factor Xase Complex* , 2009, Journal of Biological Chemistry.

[6]  C. W. Heegaard,et al.  Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure , 2008, Journal of thrombosis and haemostasis : JTH.

[7]  B. Furie,et al.  Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex. , 2008, Structure.

[8]  V. Novakovic,et al.  Crystal Structure of Lactadherin C2 Domain at 1.7Å Resolution with Mutational and Computational Analyses of Its Membrane-binding Motif* , 2008, Journal of Biological Chemistry.

[9]  B. Shen,et al.  The tertiary structure and domain organization of coagulation factor VIII. , 2008, Blood.

[10]  S. Meeks,et al.  Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation. , 2007, Blood.

[11]  J. Oldenburg,et al.  Haemophilia A: from mutation analysis to new therapies , 2005, Nature Reviews Genetics.

[12]  R. Kaufman,et al.  His2315/Gln2316 of the Factor VIII C2 Domain Interact with Phospholipid Membranes and Influence Activity of the Factor Xase Complex. , 2004 .

[13]  Friedrich Scheiflinger,et al.  Mutation of the surface‐exposed amino acid Trp2313 to Ala in the FVIII C2 domain results in defective secretion of the otherwise functional protein , 2004, British journal of haematology.

[14]  W. Bode,et al.  The factor V C1 domain is involved in membrane binding: identification of functionally important amino acid residues within the C1 domain of factor V using alanine scanning mutagenesis , 2003, Thrombosis and Haemostasis.

[15]  R. Kaufman,et al.  Four Hydrophobic Amino Acids of the Factor VIII C2 Domain Are Constituents of Both the Membrane-binding and von Willebrand Factor-binding Motifs* , 2002, The Journal of Biological Chemistry.

[16]  B. Stoddard,et al.  Structure of a factor VIII C2 domain-immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII. , 2001, Blood.

[17]  K. Fujikawa,et al.  Hemophilic factor VIII C1- and C2-domain missense mutations and their modeling to the 1.5-angstrom human C2-domain crystal structure. , 2000, Blood.

[18]  L. Alberio,et al.  Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. , 2000, Blood.

[19]  R. Huber,et al.  Crystal structures of the membrane-binding C2 domain of human coagulation factor V , 1999, Nature.

[20]  K. Fujikawa,et al.  Structure of the C2 domain of human factor VIII at 1.5 Å resolution , 1999, Nature.

[21]  M F Hoylaerts,et al.  Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. , 1998, Blood.

[22]  G. Card,et al.  A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. , 1997, Blood.

[23]  G. E. Gilbert,et al.  Activation of the Factor VIIIa-Factor IXa Enzyme Complex of Blood Coagulation by Membranes Containing Phosphatidyl-L-serine (*) , 1996, The Journal of Biological Chemistry.

[24]  P. Lenting,et al.  The Sequence GluLys of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IX (*) , 1996, The Journal of Biological Chemistry.

[25]  G. E. Gilbert,et al.  Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site. , 1995, Blood.

[26]  P. Fay,et al.  Factor VIIIa A2 subunit residues 558-565 represent a factor IXa interactive site. , 1994, The Journal of biological chemistry.

[27]  M. Shima,et al.  A Factor VIII Neutralizing Monoclonal Antibody and a Human Inhibitor Alloantibody Recognizing Epitopes in the C2 Domain Inhibit Factor VIII Binding to von Willebrand Factor and to Phosphatidylserine , 1993, Thrombosis and Haemostasis.

[28]  P. Lollar,et al.  The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study. , 1992, The Journal of biological chemistry.

[29]  G. E. Gilbert,et al.  Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). , 1992, The Journal of biological chemistry.

[30]  A. Giles,et al.  The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. , 1991, The Journal of biological chemistry.

[31]  P. Lollar.  The association of factor VIII with von Willebrand factor. , 1991, Mayo Clinic proceedings.

[32]  R. Houghten,et al.  Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. , 1990, Blood.

[33]  L. Hoyer,et al.  Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. , 1989, The Journal of clinical investigation.

[34]  B. Furie,et al.  The molecular basis of blood coagulation , 1988, Cell.

[35]  R. Houghten,et al.  An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. , 1988, The Journal of biological chemistry.

[36]  B. Keyt,et al.  Structure of human factor VIII , 1984, Nature.

[37]  E. Chen,et al.  Characterization of the human factor VIII gene , 1984, Nature.

[38]  K. Mann,et al.  Coagulation factors V and VIII and ceruloplasmin constitute a family of structurally related proteins. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Knutson,et al.  Molecular cloning of a cDNA encoding human antihaemophilic factor , 1984, Nature.

[40]  H. Hemker,et al.  Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. , 1982, European journal of biochemistry.

[41]  J. Brown,et al.  Interaction Of Factor VIII/Von Willebrand Factor With Phospholipid Vesicles , 1981, Thrombosis and Haemostasis.

[42]  H. Hemker,et al.  The role of phospholipid and factor VIIIa in the activation of bovine factor X. , 1981, The Journal of biological chemistry.

[43]  D. Barrow,et al.  Large vesicle contamination in small, unilamellar vesicles. , 1980, Biochimica et biophysica acta.

[44]  A. Thompson,et al.  The factor VIII C1 domain contributes to platelet binding. , 2008, Blood.

[45]  P. Fay,et al.  Mutating factor VIII: lessons from structure to function. , 2005, Blood reviews.

[46]  B. Villoutreix,et al.  HEMOSTASIS , THROMBOSIS , AND VASCULAR BIOLOGY 3-Dimensional structure of membrane-bound coagulation factor VIII : modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography , 2002 .